+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Indocyanine Green Market - Global Forecast 2026-2032- Product Image
Indocyanine Green Market - Global Forecast 2026-2032- Product Image
Sale

Indocyanine Green Market - Global Forecast 2026-2032

  • Report

  • 189 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6153077
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Indocyanine Green Market is projected to reach USD 315.36 Million in 2026. It is expected to continue growing at a CAGR of 9.01%, reaching USD 527.34 Million by 2032.

Indocyanine Green: Executive Overview

Indocyanine green (ICG) is a near-infrared fluorescent dye used primarily for diagnostic imaging and visualization during medical procedures. Its established applications include ophthalmology, hepatobiliary assessment, cardiovascular evaluation, lymphatic mapping, and image-guided surgery. Adoption is shaped by clinical evidence, regulatory requirements, imaging-platform availability, reimbursement conditions, and hospital workflow integration.

Clinical Workflow Integration Is Reshaping ICG Use

The landscape is shifting from standalone dye administration toward integrated fluorescence-guided workflows. Improvements in near-infrared cameras, surgical navigation, minimally invasive techniques, and procedure-specific protocols are expanding the settings in which ICG can support real-time visualization. At the same time, users continue to emphasize dosing consistency, sterility, contraindication screening, operator training, and dependable supply because these factors directly affect procedural safety and reproducibility.

Artificial Intelligence Strengthens Interpretation and Procedure Support

Artificial intelligence is increasingly relevant to ICG-enabled imaging through automated image enhancement, tissue and vessel segmentation, perfusion assessment, and decision support. Its practical value depends on high-quality annotated datasets, standardized acquisition protocols, transparent validation, and integration with clinical systems. AI can improve consistency and reduce interpretation burden, but it does not eliminate the need for clinician oversight, regulatory review, or careful management of false-positive and false-negative results.

Regional Insights: Adoption Reflects Infrastructure and Clinical Specialization

North America benefits from advanced surgical infrastructure, established fluorescence-imaging use, and strong clinical research networks. Europe combines mature hospital systems with close attention to evidence, safety, and data governance, while the European Union’s harmonized regulatory environment can support cross-border adoption. Asia-Pacific includes highly capable technology and research centers alongside substantial variation in access, procurement, and training. Latin America is influenced by urban concentration of specialist care, import dependence, and uneven reimbursement. The Middle East is developing advanced procedural capacity through tertiary-care investment, particularly in major hubs. Africa presents differentiated opportunities where specialist centers, surgical access, supply reliability, and workforce development are strengthened together.

Group Insights: Trade, Regulation, and Collaboration Shape Access

ASEAN markets are connected by growing healthcare collaboration but differ considerably in regulatory maturity, procurement systems, and specialist availability. BRICS countries span large and diverse healthcare environments, with opportunities linked to domestic manufacturing, public-sector purchasing, and expansion of advanced surgical services. The European Union emphasizes common regulatory expectations, clinical evidence, and interoperability. G7 members generally combine sophisticated imaging infrastructure with demanding safety and reimbursement standards. GCC countries are supported by concentrated investment in tertiary care and medical technology, while NATO members represent a broad set of healthcare systems where resilience, procurement continuity, and cross-border clinical collaboration can influence access.

Country Insights: Diverse Clinical Capacity Requires Localized Strategies

Australia and Canada have advanced clinical systems but geographically dispersed service delivery. Brazil, Mexico, India, and Russia combine major tertiary-care capabilities with significant regional variation in access and procurement. China, Japan, and South Korea possess strong hospital technology ecosystems, with adoption influenced by domestic regulatory pathways and clinical training. France, Germany, Italy, Spain, and the United Kingdom have established specialist care and structured evidence requirements, although purchasing and reimbursement processes differ. The United States has broad access to advanced procedural imaging, with utilization shaped by institutional protocols, regulatory compliance, and payer considerations.

Recommendations for Leaders: Build Evidence, Reliability, and Workflow Value

Industry leaders should prioritize indication-specific clinical evidence and publish protocols that clarify patient selection, dosing, imaging settings, and interpretation. They should strengthen supply resilience through validated quality systems, dependable cold-chain or storage practices where applicable, and contingency planning. Partnerships with hospitals and professional societies can support training, standardized workflows, and responsible adoption. Investment in interoperable imaging software and carefully validated AI tools should focus on measurable clinical utility rather than novelty. Regional strategies should be localized around regulatory requirements, reimbursement pathways, specialist density, and public-sector procurement practices.

Research Methodology: Evidence-Led Market Assessment

This executive summary is based on structured analysis of the indocyanine green clinical and commercial landscape, including documented medical applications, regulatory considerations, healthcare infrastructure, procedural trends, technology integration, and geographic differences in access. Regional, group, and country observations are synthesized from established characteristics of healthcare delivery and medical-device adoption. Claims are framed qualitatively to avoid unsupported estimates, market sizing, market shares, or forecasts; interpretation should be supplemented with current regulatory documents, peer-reviewed evidence, procurement data, and local clinical guidance.

Conclusion: ICG’s Role Depends on Clinically Integrated Adoption

Indocyanine green remains a versatile imaging adjunct whose value is strongest when the dye, imaging hardware, clinical protocol, and trained care team operate as one system. Future progress will depend less on fluorescence capability alone and more on evidence quality, workflow reliability, responsible AI integration, equitable access, and region-specific implementation. Organizations that connect these elements can improve the consistency and practical usefulness of ICG-enabled care while maintaining appropriate safety and oversight.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Indocyanine Green Market, by Product Type
7.1. Introduction
7.2. Dry Powder
7.3. Liquid
8. Indocyanine Green Market, by Application
8.1. Introduction
8.2. Cancer Detection
8.3. Cardiac Output Measurement
8.3.1. Cardiac Surgery Patients
8.3.2. Heart Failure Patients
8.4. Fluorescence Imaging
8.4.1. Angiography
8.4.2. Guided Resection
8.4.3. Lymphography
8.4.4. Minimally Invasive Surgery
8.5. Liver Function Test
8.6. Ophthalmology
9. Indocyanine Green Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Hospitals
9.4. Research Institutes
10. Indocyanine Green Market, by Region
10.1. Introduction
10.2. Asia-Pacific
10.3. North America
10.4. Latin America
10.5. Europe
10.6. Middle East
10.7. Africa
11. Indocyanine Green Market, by Group
11.1. Introduction
11.2. ASEAN
11.3. GCC
11.4. European Union
11.5. BRICS
11.6. G7
11.7. NATO
12. Indocyanine Green Market, by Country
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. United Kingdom
12.7. Germany
12.8. France
12.9. Russia
12.10. Italy
12.11. Spain
12.12. China
12.13. India
12.14. Japan
12.15. Australia
12.16. South Korea
13. Competitive Landscape
13.1. Market Share Analysis, 2025
13.2. Market Concentration Analysis, 2025
13.2.1. Concentration Ratio (CR)
13.2.2. Herfindahl Hirschman Index (HHI)
13.3. Recent Developments & Impact Analysis, 2025
13.4. Product Portfolio Analysis, 2025
13.5. Benchmarking Analysis, 2025
14. Company Profiles
14.1. ChemWerth Inc.
14.2. Chongqing Huading Modern Biological Products Co., Ltd.
14.3. Daiichi Sankyo Company
14.4. Diagnostic Green GmbH
14.5. Manus Aktteva Biopharma LLP:
14.6. MedChemExpress LLC
14.7. Merck KGaA
14.8. PULSION Medical Systems AG
14.9. RayBright Life Sciences Co., Ltd.
14.10. Santen Pharmaceutical Co., Ltd
14.11. Senju Pharmaceutical Co., Ltd.
14.12. Shanghai Haling Biotechnology Co., Ltd.
14.13. Shenzhen Ruichuan Biotechnology Co., Ltd.
14.14. Sigma-Aldrich Co. LLC
14.15. Tokyo Chemical Industry Co., Ltd.
15. Key Experts
LIST OF FIGURES
FIGURE 1. Global Indocyanine Green Market, Years Considered for the Study
FIGURE 2. Global Indocyanine Green Market, Research Design
FIGURE 3. Global Indocyanine Green Market, Research Framework
FIGURE 4. Global Indocyanine Green Market, Data Triangulation
FIGURE 5. Global Indocyanine Green Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Indocyanine Green Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Indocyanine Green Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Indocyanine Green Market Size, by Application, 2025 vs 2032 (%)
FIGURE 9. Global Indocyanine Green Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Indocyanine Green Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Indocyanine Green Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Indocyanine Green Market Size, by Region, 2025 vs 2032 (%)
FIGURE 13. Global Indocyanine Green Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Indocyanine Green Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 15. Global Indocyanine Green Market Size, by Country, 2025 vs 2032 (%)
FIGURE 16. Global Indocyanine Green Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Indocyanine Green Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Indocyanine Green Market Segmentation & Coverage
TABLE 2. Global Indocyanine Green Market Size, 2017-2032 (USD Million)
TABLE 3. Global Indocyanine Green Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Dry Powder Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Dry Powder Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Dry Powder Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Liquid Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Liquid Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Liquid Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Indocyanine Green Market Size, by Application, 2017-2032 (USD Million)
TABLE 11. Global Cancer Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Cancer Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Cancer Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Cardiac Output Measurement Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Cardiac Output Measurement Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Cardiac Output Measurement Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Cardiac Surgery Patients Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Cardiac Surgery Patients Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Cardiac Surgery Patients Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Heart Failure Patients Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Heart Failure Patients Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Heart Failure Patients Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Fluorescence Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Fluorescence Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Fluorescence Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Angiography Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Angiography Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Angiography Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Guided Resection Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Guided Resection Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Guided Resection Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Lymphography Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Lymphography Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Lymphography Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Minimally Invasive Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Minimally Invasive Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Minimally Invasive Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Liver Function Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Liver Function Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Liver Function Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Ophthalmology Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Ophthalmology Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Ophthalmology Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Indocyanine Green Market Size, by End User, 2017-2032 (USD Million)
TABLE 45. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Indocyanine Green Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Asia-Pacific Indocyanine Green Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Asia-Pacific Indocyanine Green Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 57. Asia-Pacific Indocyanine Green Market Size, by Application, 2017-2032 (USD Million)
TABLE 58. Asia-Pacific Indocyanine Green Market Size, by Cardiac Output Measurement, 2017-2032 (USD Million)
TABLE 59. Asia-Pacific Indocyanine Green Market Size, by Fluorescence Imaging, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Indocyanine Green Market Size, by End User, 2017-2032 (USD Million)
TABLE 61. North America Indocyanine Green Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. North America Indocyanine Green Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 63. North America Indocyanine Green Market Size, by Application, 2017-2032 (USD Million)
TABLE 64. North America Indocyanine Green Market Size, by Cardiac Output Measurement, 2017-2032 (USD Million)
TABLE 65. North America Indocyanine Green Market Size, by Fluorescence Imaging, 2017-2032 (USD Million)
TABLE 66. North America Indocyanine Green Market Size, by End User, 2017-2032 (USD Million)
TABLE 67. Latin America Indocyanine Green Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Latin America Indocyanine Green Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 69. Latin America Indocyanine Green Market Size, by Application, 2017-2032 (USD Million)
TABLE 70. Latin America Indocyanine Green Market Size, by Cardiac Output Measurement, 2017-2032 (USD Million)
TABLE 71. Latin America Indocyanine Green Market Size, by Fluorescence Imaging, 2017-2032 (USD Million)
TABLE 72. Latin America Indocyanine Green Market Size, by End User, 2017-2032 (USD Million)
TABLE 73. Europe Indocyanine Green Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Europe Indocyanine Green Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 75. Europe Indocyanine Green Market Size, by Application, 2017-2032 (USD Million)
TABLE 76. Europe Indocyanine Green Market Size, by Cardiac Output Measurement, 2017-2032 (USD Million)
TABLE 77. Europe Indocyanine Green Market Size, by Fluorescence Imaging, 2017-2032 (USD Million)
TABLE 78. Europe Indocyanine Green Market Size, by End User, 2017-2032 (USD Million)
TABLE 79. Middle East Indocyanine Green Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Middle East Indocyanine Green Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 81. Middle East Indocyanine Green Market Size, by Application, 2017-2032 (USD Million)
TABLE 82. Middle East Indocyanine Green Market Size, by Cardiac Output Measurement, 2017-2032 (USD Million)
TABLE 83. Middle East Indocyanine Green Market Size, by Fluorescence Imaging, 2017-2032 (USD Million)
TABLE 84. Middle East Indocyanine Green Market Size, by End User, 2017-2032 (USD Million)
TABLE 85. Africa Indocyanine Green Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Africa Indocyanine Green Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 87. Africa Indocyanine Green Market Size, by Application, 2017-2032 (USD Million)
TABLE 88. Africa Indocyanine Green Market Size, by Cardiac Output Measurement, 2017-2032 (USD Million)
TABLE 89. Africa Indocyanine Green Market Size, by Fluorescence Imaging, 2017-2032 (USD Million)
TABLE 90. Africa Indocyanine Green Market Size, by End User, 2017-2032 (USD Million)
TABLE 91. Global Indocyanine Green Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. ASEAN Indocyanine Green Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. ASEAN Indocyanine Green Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 94. ASEAN Indocyanine Green Market Size, by Application, 2017-2032 (USD Million)
TABLE 95. ASEAN Indocyanine Green Market Size, by Cardiac Output Measurement, 2017-2032 (USD Million)
TABLE 96. ASEAN Indocyanine Green Market Size, by Fluorescence Imaging, 2017-2032 (USD Million)
TABLE 97. ASEAN Indocyanine Green Market Size, by End User, 2017-2032 (USD Million)
TABLE 98. GCC Indocyanine Green Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. GCC Indocyanine Green Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 100. GCC Indocyanine Green Market Size, by Application, 2017-2032 (USD Million)
TABLE 101. GCC Indocyanine Green Market Size, by Cardiac Output Measurement, 2017-2032 (USD Million)
TABLE 102. GCC Indocyanine Green Market Size, by Fluorescence Imaging, 2017-2032 (USD Million)
TABLE 103. GCC Indocyanine Green Market Size, by End User, 2017-2032 (USD Million)
TABLE 104. European Union Indocyanine Green Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. European Union Indocyanine Green Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 106. European Union Indocyanine Green Market Size, by Application, 2017-2032 (USD Million)
TABLE 107. European Union Indocyanine Green Market Size, by Cardiac Output Measurement, 2017-2032 (USD Million)
TABLE 108. European Union Indocyanine Green Market Size, by Fluorescence Imaging, 2017-2032 (USD Million)
TABLE 109. European Union Indocyanine Green Market Size, by End User, 2017-2032 (USD Million)
TABLE 110. BRICS Indocyanine Green Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. BRICS Indocyanine Green Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 112. BRICS Indocyanine Green Market Size, by Application, 2017-2032 (USD Million)
TABLE 113. BRICS Indocyanine Green Market Size, by Cardiac Output Measurement, 2017-2032 (USD Million)
TABLE 114. BRICS Indocyanine Green Market Size, by Fluorescence Imaging, 2017-2032 (USD Million)
TABLE 115. BRICS Indocyanine Green Market Size, by End User, 2017-2032 (USD Million)
TABLE 116. G7 Indocyanine Green Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. G7 Indocyanine Green Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 118. G7 Indocyanine Green Market Size, by Application, 2017-2032 (USD Million)
TABLE 119. G7 Indocyanine Green Market Size, by Cardiac Output Measurement, 2017-2032 (USD Million)
TABLE 120. G7 Indocyanine Green Market Size, by Fluorescence Imaging, 2017-2032 (USD Million)
TABLE 121. G7 Indocyanine Green Market Size, by End User, 2017-2032 (USD Million)
TABLE 122. NATO Indocyanine Green Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. NATO Indocyanine Green Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 124. NATO Indocyanine Green Market Size, by Application, 2017-2032 (USD Million)
TABLE 125. NATO Indocyanine Green Market Size, by Cardiac Output Measurement, 2017-2032 (USD Million)
TABLE 126. NATO Indocyanine Green Market Size, by Fluorescence Imaging, 2017-2032 (USD Million)
TABLE 127. NATO Indocyanine Green Market Size, by End User, 2017-2032 (USD Million)
TABLE 128. Global Indocyanine Green Market Size, by Country, 2017-2032 (USD Million)
TABLE 129. United States Indocyanine Green Market Size, 2017-2032 (USD Million)
TABLE 130. United States Indocyanine Green Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 131. United States Indocyanine Green Market Size, by Application, 2017-2032 (USD Million)
TABLE 132. United States Indocyanine Green Market Size, by Cardiac Output Measurement, 2017-2032 (USD Million)
TABLE 133. United States Indocyanine Green Market Size, by Fluorescence Imaging, 2017-2032 (USD Million)
TABLE 134. United States Indocyanine Green Market Size, by End User, 2017-2032 (USD Million)
TABLE 135. Canada Indocyanine Green Market Size, 2017-2032 (USD Million)
TABLE 136. Canada Indocyanine Green Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 137. Canada Indocyanine Green Market Size, by Application, 2017-2032 (USD Million)
TABLE 138. Canada Indocyanine Green Market Size, by Cardiac Output Measurement, 2017-2032 (USD Million)
TABLE 139. Canada Indocyanine Green Market Size, by Fluorescence Imaging, 2017-2032 (USD Million)
TABLE 140. Canada Indocyanine Green Market Size, by End User, 2017-2032 (USD Million)
TABLE 141. Mexico Indocyanine Green Market Size, 2017-2032 (USD Million)
TABLE 142. Mexico Indocyanine Green Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 143. Mexico Indocyanine Green Market Size, by Application, 2017-2032 (USD Million)
TABLE 144. Mexico Indocyanine Green Market Size, by Cardiac Output Measurement, 2017-2032 (USD Million)
TABLE 145. Mexico Indocyanine Green Market Size, by Fluorescence Imaging, 2017-2032 (USD Million)
TABLE 146. Mexico Indocyanine Green Market Size, by End User, 2017-2032 (USD Million)
TABLE 147. Brazil Indocyanine Green Market Size, 2017-2032 (USD Million)
TABLE 148. Brazil Indocyanine Green Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 149. Brazil Indocyanine Green Market Size, by Application, 2017-2032 (USD Million)
TABLE 150. Brazil Indocyanine Green Market Size, by Cardiac Output Measurement, 2017-2032 (USD Million)
TABLE 151. Brazil Indocyanine Green Market Size, by Fluorescence Imaging, 2017-2032 (USD Million)
TABLE 152. Brazil Indocyanine Green Market Size, by End User, 2017-2032 (USD Million)
TABLE 153. United Kingdom Indocyanine Green Market Size, 2017-2032 (USD Million)
TABLE 154. United Kingdom Indocyanine Green Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 155. United Kingdom Indocyanine Green Market Size, by Application, 2017-2032 (USD Million)
TABLE 156. United Kingdom Indocyanine Green Market Size, by Cardiac Output Measurement, 2017-2032 (USD Million)
TABLE 157. United Kingdom Indocyanine Green Market Size, by Fluorescence Imaging, 2017-2032 (USD Million)
TABLE 158. United Kingdom Indocyanine Green Market Size, by End User, 2017-2032 (USD Million)
TABLE 159. Germany Indocyanine Green Market Size, 2017-2032 (USD Million)
TABLE 160. Germany Indocyanine Green Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 161. Germany Indocyanine Green Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. Germany Indocyanine Green Market Size, by Cardiac Output Measurement, 2017-2032 (USD Million)
TABLE 163. Germany Indocyanine Green Market Size, by Fluorescence Imaging, 2017-2032 (USD Million)
TABLE 164. Germany Indocyanine Green Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. France Indocyanine Green Market Size, 2017-2032 (USD Million)
TABLE 166. France Indocyanine Green Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 167. France Indocyanine Green Market Size, by Application, 2017-2032 (USD Million)
TABLE 168. France Indocyanine Green Market Size, by Cardiac Output Measurement, 2017-2032 (USD Million)
TABLE 169. France Indocyanine Green Market Size, by Fluorescence Imaging, 2017-2032 (USD Million)
TABLE 170. France Indocyanine Green Market Size, by End User, 2017-2032 (USD Million)
TABLE 171. Russia Indocyanine Green Market Size, 2017-2032 (USD Million)
TABLE 172. Russia Indocyanine Green Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 173. Russia Indocyanine Green Market Size, by Application, 2017-2032 (USD Million)
TABLE 174. Russia Indocyanine Green Market Size, by Cardiac Output Measurement, 2017-2032 (USD Million)
TABLE 175. Russia Indocyanine Green Market Size, by Fluorescence Imaging, 2017-2032 (USD Million)
TABLE 176. Russia Indocyanine Green Market Size, by End User, 2017-2032 (USD Million)
TABLE 177. Italy Indocyanine Green Market Size, 2017-2032 (USD Million)
TABLE 178. Italy Indocyanine Green Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 179. Italy Indocyanine Green Market Size, by Application, 2017-2032 (USD Million)
TABLE 180. Italy Indocyanine Green Market Size, by Cardiac Output Measurement, 2017-2032 (USD Million)
TABLE 181. Italy Indocyanine Green Market Size, by Fluorescence Imaging, 2017-2032 (USD Million)
TABLE 182. Italy Indocyanine Green Market Size, by End User, 2017-2032 (USD Million)
TABLE 183. Spain Indocyanine Green Market Size, 2017-2032 (USD Million)
TABLE 184. Spain Indocyanine Green Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 185. Spain Indocyanine Green Market Size, by Application, 2017-2032 (USD Million)
TABLE 186. Spain Indocyanine Green Market Size, by Cardiac Output Measurement, 2017-2032 (USD Million)
TABLE 187. Spain Indocyanine Green Market Size, by Fluorescence Imaging, 2017-2032 (USD Million)
TABLE 188. Spain Indocyanine Green Market Size, by End User, 2017-2032 (USD Million)
TABLE 189. China Indocyanine Green Market Size, 2017-2032 (USD Million)
TABLE 190. China Indocyanine Green Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 191. China Indocyanine Green Market Size, by Application, 2017-2032 (USD Million)
TABLE 192. China Indocyanine Green Market Size, by Cardiac Output Measurement, 2017-2032 (USD Million)
TABLE 193. China Indocyanine Green Market Size, by Fluorescence Imaging, 2017-2032 (USD Million)
TABLE 194. China Indocyanine Green Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. India Indocyanine Green Market Size, 2017-2032 (USD Million)
TABLE 196. India Indocyanine Green Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 197. India Indocyanine Green Market Size, by Application, 2017-2032 (USD Million)
TABLE 198. India Indocyanine Green Market Size, by Cardiac Output Measurement, 2017-2032 (USD Million)
TABLE 199. India Indocyanine Green Market Size, by Fluorescence Imaging, 2017-2032 (USD Million)
TABLE 200. India Indocyanine Green Market Size, by End User, 2017-2032 (USD Million)
TABLE 201. Japan Indocyanine Green Market Size, 2017-2032 (USD Million)
TABLE 202. Japan Indocyanine Green Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 203. Japan Indocyanine Green Market Size, by Application, 2017-2032 (USD Million)
TABLE 204. Japan Indocyanine Green Market Size, by Cardiac Output Measurement, 2017-2032 (USD Million)
TABLE 205. Japan Indocyanine Green Market Size, by Fluorescence Imaging, 2017-2032 (USD Million)
TABLE 206. Japan Indocyanine Green Market Size, by End User, 2017-2032 (USD Million)
TABLE 207. Australia Indocyanine Green Market Size, 2017-2032 (USD Million)
TABLE 208. Australia Indocyanine Green Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 209. Australia Indocyanine Green Market Size, by Application, 2017-2032 (USD Million)
TABLE 210. Australia Indocyanine Green Market Size, by Cardiac Output Measurement, 2017-2032 (USD Million)
TABLE 211. Australia Indocyanine Green Market Size, by Fluorescence Imaging, 2017-2032 (USD Million)
TABLE 212. Australia Indocyanine Green Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. South Korea Indocyanine Green Market Size, 2017-2032 (USD Million)
TABLE 214. South Korea Indocyanine Green Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 215. South Korea Indocyanine Green Market Size, by Application, 2017-2032 (USD Million)
TABLE 216. South Korea Indocyanine Green Market Size, by Cardiac Output Measurement, 2017-2032 (USD Million)
TABLE 217. South Korea Indocyanine Green Market Size, by Fluorescence Imaging, 2017-2032 (USD Million)
TABLE 218. South Korea Indocyanine Green Market Size, by End User, 2017-2032 (USD Million)
TABLE 219. Global Indocyanine Green Market Share, by Key Player, 2025
TABLE 220. Global Indocyanine Green Market, Key Experts

Companies Mentioned

  • ChemWerth Inc.
  • Chongqing Huading Modern Biological Products Co., Ltd.
  • Daiichi Sankyo Company
  • Diagnostic Green GmbH
  • Manus Aktteva Biopharma LLP:
  • MedChemExpress LLC
  • Merck KGaA
  • PULSION Medical Systems AG
  • RayBright Life Sciences Co., Ltd.
  • Santen Pharmaceutical Co., Ltd
  • Senju Pharmaceutical Co., Ltd.
  • Shanghai Haling Biotechnology Co., Ltd.
  • Shenzhen Ruichuan Biotechnology Co., Ltd.
  • Sigma-Aldrich Co. LLC
  • Tokyo Chemical Industry Co., Ltd.

Related Topics

Related Reports

Global Indocyanine Green (ICG) Market Research Report 2026-2031 - Product Image

Global Indocyanine Green (ICG) Market Research Report 2026-2031

  • Report
  • 204 Pages
  • Global
From
Indocyanine Green (CAS 3599-32-4) Market Research Report 2019 - Product Image

Indocyanine Green (CAS 3599-32-4) Market Research Report 2019

  • Report
  • 69 Pages
  • Global
Pigments Market Report by Product Type, Color Index, Application, and Region 2026-2034 - Product Image

Pigments Market Report by Product Type, Color Index, Application, and Region 2026-2034

  • Report
  • 147 Pages
  • Global
From
Organic Pigments for Paint Market - Global Forecast 2026-2032 - Product Image

Organic Pigments for Paint Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Industrial Colorants Market - Global Forecast 2026-2032 - Product Image

Industrial Colorants Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.